It should be the other way around. If an American company, develops and produces a drug in the United States, then the American people pay exponentially less than the folks across the seas. In short, if big pharma wants to stay big they charge non Americans through the rear end. Ideally this forces overseas govs and pharma companies to develop their own drugs to level the playing field. Presto, big pharma ain't so big no more